CELLOMICS INC
S-1/A, EX-27, 2000-09-05
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: CELLOMICS INC, S-1/A, EX-23.1, 2000-09-05
Next: NIAGARA MOHAWK HOLDINGS INC/NY, DEFA14A, 2000-09-05



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from unaudited
interim financial statements as of and for the six months ended June 30, 2000
and is qualified in its entirety by such financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                         852,306
<SECURITIES>                                         0
<RECEIVABLES>                                2,493,842
<ALLOWANCES>                                         0
<INVENTORY>                                    366,374
<CURRENT-ASSETS>                             5,323,337
<PP&E>                                       3,758,275
<DEPRECIATION>                             (1,040,718)
<TOTAL-ASSETS>                               8,040,894
<CURRENT-LIABILITIES>                        5,628,642
<BONDS>                                              0
                       20,915,695
                                          0
<COMMON>                                        41,830
<OTHER-SE>                                (21,168,458)
<TOTAL-LIABILITY-AND-EQUITY>              (21,126,628)
<SALES>                                      3,055,604
<TOTAL-REVENUES>                             3,986,818
<CGS>                                        1,209,017
<TOTAL-COSTS>                               10,844,023
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           1,886,528
<INCOME-PRETAX>                            (8,743,733)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (8,743,733)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (8,743,733)
<EPS-BASIC>                                     (3.79)
<EPS-DILUTED>                                   (3.79)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission